Table 1.
Characteristics | Healthy Controls | CIN | CESC |
---|---|---|---|
Age (years) | |||
≤49 | 54 | 38 | 64 |
>49 | 47 | 41 | 51 |
Menopause age (years) | |||
<49 | – | – | 55 |
≥49 | – | – | 60 |
FIGO stage | |||
Ι | – | – | 62 |
ΙΙ+ΙΙΙ+ΙV | – | – | 53 |
Tumor size | |||
<3.5 cm | – | – | 53 |
≥3.5 cm | – | – | 62 |
Lymphatic metastasis | |||
N0 | – | – | 73 |
N1 or above | – | – | 42 |
The grade of tumor differentiation | |||
Poor | – | – | 56 |
Moderate and Well | – | – | 59 |
SCC* | |||
Positive | – | – | 84 |
Negative | – | – | 31 |
Notes: *SCC reference range is 0–1.5ng/mL. SCC≥1.5ng/mL is defined as positive. Negative:<1.5ng/mL.